FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064048 [Registered on: 13/03/2024] Trial Registered Prospectively
Last Modified On: 26/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Prospective Comparative study 
Study Design  Single Arm Study 
Public Title of Study   USG vs Frozen section for intraoperative deep margins in carcinoma tongue 
Scientific Title of Study   Comparing Ex-Vivo Ultrasound aided and Frozen section analysis of deep margins with Final Histopathology in T1-T4 Carcinoma Tongue: A Prospective study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Nivedhitha Murugesan 
Designation  Junior Resident 
Affiliation  AIIMS NEW DELHI 
Address  Department of Otorhinolaryngology and Head & Neck Surgery, Room no. 4057, ENT Office, 4th Floor, Teaching Block, AIIMS, New Delhi, India.

New Delhi
DELHI
110029
India 
Phone  9150054466  
Fax    
Email  nivedhitham2016@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Rajeev Kumar 
Designation  Additional Professor 
Affiliation  AIIMS NEW DELHI 
Address  Department of Otorhinolaryngology and Head & Neck Surgery, Room no. 4057, ENT Office, 4th Floor, Teaching Block, AIIMS, New Delhi, India.

New Delhi
DELHI
110029
India 
Phone  9968569892  
Fax    
Email  rajeev9843@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Nivedhitha Murugesan 
Designation  Junior Resident 
Affiliation  AIIMS NEW DELHI 
Address  Department of Otorhinolaryngology and Head & Neck Surgery, Room no. 4057, ENT Office, 4th Floor, Teaching Block, AIIMS, New Delhi, India.

New Delhi
DELHI
110029
India 
Phone  9150054466  
Fax    
Email  nivedhitham2016@gmail.com  
 
Source of Monetary or Material Support  
AIIMS NEW DELHI Sri Aurobindo Marg, Ansari Nagar, Ansari Nagar East, New Delhi, Delhi 110029 
 
Primary Sponsor  
Name  AIIMS NEW DELHI 
Address  Sri Aurobindo Marg, Ansari Nagar, Ansari Nagar East, New Delhi, Delhi 110029 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nivedhitha Murugesan  AIIMS NEW DELHI  Department of Otorhinolaryngology and Head & Neck Surgery, Room no. 4057, ENT Office, 4th Floor, Teaching Block, AIIMS, New Delhi, India.
New Delhi
DELHI 
9150054466

nivedhithamurugesan2016@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee for biomedical and Health Research, AIIMS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C021||Malignant neoplasm of border of tongue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  7.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1.Patient planned for surgery with biopsy proven Squamous Cell Carcinoma Lateral border of Tongue T1-T4 anyN M0.
2.Patient giving consent to participate in study.
 
 
ExclusionCriteria 
Details  1.Patient who is not willing to participate in the study.
2.Patient is unfit for surgery under general anesthesia.
3.Patients of Carcinoma Tongue with metastasis M1.
4.Patients of Carcinoma Tongue any stage who have undergone Neoadjuvant Chemotherapy/Post op Chemotherapy and Radiotherapy. 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
1.To determine accuracy of USG aided ex-vivo deep margin assessment with final histopathology.
2.To determine accuracy of frozen section analysis for deep margin assessment with final histopathology. 
2 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To compare both techniques USG guided & Frozen section with respect to final histopathology  2 weeks 
 
Target Sample Size
Modification(s)  
Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The preferred modality of treatment for squamous cell carcinoma tongue is surgical resection. Free margin status >5mm is essential for local control and disease free survival. Submucosal or deep margins are often inadequate. Because patients with involved and close margins may require additional surges or adjuvant (chemo)radiotherapy, there is a need for technology that can provide real time, intraoperative feedback on margins. In this trial, we are going to determine the accuracy and consistency between ex vivo ultrasound aided and frozen section analysis of resected specimen to final histopathology in oral tongue squamous cell carcinoma. 
Close